165 JNJ-26483327, a second-generation spectrum-targeted protein tyrosine kinase inhibitor with superior characteristics in advanced cancer models — Burkhard Haefner (2010) | RDL Network
Adrian T. Press, Petra Babic, Bianca Hoffmann, Tina Müller, Wanling Foo, Walter Hauswald, Jovana Benecke, Martina Beretta, Zoltán Cseresnyés, Stephanie Hoeppener, Ivo Nischang, Sina M. Coldewey, Markus H. Gräler, Reinhard Bauer, Falk A. Gonnert, Nikolaus Gaßler, Reinhard Wetzker, Marc Thilo Figge, Ulrich Sigmar Schubert, Michael Bauer
Discussion(0)
No comments yet. Be the first to comment.